...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Expands Phase 2b Clinical Trial for COVID-19

Well that's good news - although it took longer than expected. New cases in Brazil are declining from recent peak although new cases are >100k per day with an abundant hospitalization rate. Let's hope that Apabetalone proves to be an effective long and short term therapy both in Canada and Brazil.

 https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/brazil/

Chicagoest

Share
New Message
Please login to post a reply